{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_bleomycin",
          "name": "Bleomycin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_ifosfamide",
          "name": "Ifosfamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_nitrosoureas",
          "name": "Nitrosoureas"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_procarbazine",
          "name": "Procarbazine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_bleomycin",
          "type": "Drug",
          "label": "Bleomycin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ifosfamide",
          "type": "Drug",
          "label": "Ifosfamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_nitrosoureas",
          "type": "Drug",
          "label": "Nitrosoureas",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_procarbazine",
          "type": "Drug",
          "label": "Procarbazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTarget",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_advPhenotype",
          "type": "Phenotype",
          "label": "Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_cyclophosphamide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_doxorubicin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_temozolomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_vincristine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_etoposide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_bleomycin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_ifosfamide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_nitrosoureas",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_procarbazine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_bortezomib",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_thalidomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "引发相关风险通路"
        },
        {
          "source": "n_rp",
          "target": "n_advPhenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_advPhenotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Cyclophosphamide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Doxorubicin 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Temozolomide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Vincristine 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Etoposide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Bleomycin 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Ifosfamide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Nitrosoureas 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Methotrexate 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Procarbazine 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Bortezomib 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Thalidomide 的净获益"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "drug_safety_in_familial_tumor_syndromes",
          "pro_nodes": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5",
            "H6",
            "H7",
            "H8",
            "H9",
            "H10",
            "H11",
            "H12"
          ],
          "con_nodes": [
            "n_advPhenotype"
          ],
          "note": "各种药物在遗传肿瘤综合征中可能引发不良反应"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "家族性肿瘤综合征患者可能对某些药物有更高的敏感性，导致不良反应增加。",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "药物的作用机制可能与肿瘤相关的基因突变相互作用，增加不良表型的风险。",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "药物在家族性肿瘤综合征患者中的安全性是否充分评估",
      "药物的机制是否可能遭到基因组影响"
    ],
    "falsification_tests": [
      "是否有研究表明这些药物在家族性肿瘤综合征中的长期后果？",
      "是否有证据支持这些药物无不良反应风险？"
    ],
    "next_focus_for_pi": [
      "要求提供影响安全性的数据和证据",
      "寻找其他可能的风险因素和机制信息"
    ]
  }
}